Mohamad Makhzoumi - Net Worth and Insider Trading

Mohamad Makhzoumi Net Worth

The estimated net worth of Mohamad Makhzoumi is at least $1.1 Billion dollars as of 2024-04-28. Mohamad Makhzoumi is the Director of Robinhood Markets Inc and owns about 23,829,279 shares of Robinhood Markets Inc (HOOD) stock worth over $426 Million. Mohamad Makhzoumi is the 10% Owner of Arcellx Inc and owns about 4,745,545 shares of Arcellx Inc (ACLX) stock worth over $246 Million. Mohamad Makhzoumi is also the 10% Owner of Savara Inc and owns about 24,471,264 shares of Savara Inc (SVRA) stock worth over $108 Million. Besides these, Mohamad Makhzoumi also holds Mirum Pharmaceuticals Inc (MIRM) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) . Details can be seen in Mohamad Makhzoumi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mohamad Makhzoumi has not made any transactions after 2024-04-22 and currently still holds the listed stock(s).

Transaction Summary of Mohamad Makhzoumi

To

Mohamad Makhzoumi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mohamad Makhzoumi owns 33 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Inozyme Pharma Inc (INZY) among others .

Click here to see the complete history of Mohamad Makhzoumi’s form 4 insider trades.

Insider Ownership Summary of Mohamad Makhzoumi

Ticker Comapny Transaction Date Type of Owner
EAR Eargo Inc 2020-10-20 10 percent owner
MTCR Metacrine Inc 2021-12-22 10 percent owner
INZY Inozyme Pharma Inc 2020-07-28 10 percent owner
GNCAQ Genocea Biosciences Inc 2022-05-25 10 percent owner
ANNX Annexon Inc 2020-07-23 10 percent owner
NKTX Nkarta Inc 2020-07-09 10 percent owner
AKUS Akouos Inc 2020-06-30 10 percent owner
AVEO AVEO Pharmaceuticals Inc 2020-06-19 10 percent owner
TRVI Trevi Therapeutics Inc 2022-04-11 10 percent owner
BDTX Black Diamond Therapeutics Inc 2020-01-29 10 percent owner
RGLS Regulus Therapeutics Inc 2020-12-04 10 percent owner
ARDX Ardelyx Inc 2018-06-01 10 percent owner
MIRM Mirum Pharmaceuticals Inc 2019-07-22 10 percent owner
NITE Nightstar Therapeutics PLC 2019-06-07 10 percent owner
MLND Millendo Therapeutics Inc 2018-12-07 10 percent owner
MRKR Marker Therapeutics Inc 2021-03-16 10 percent owner
AKAOQ Achaogen Inc 2018-06-01 10 percent owner
XFOR X4 Pharmaceuticals Inc 2017-11-20 10 percent owner
SVRA Savara Inc 2023-07-17 10 percent owner
TPST Tempest Therapeutics Inc 2018-12-07 10 percent owner
RPHM Reneo Pharmaceuticals Inc 2021-04-08 10 percent owner
VRNA Verona Pharma PLC 2021-01-01 10 percent owner
NEUE NeueHealth Inc 2021-06-24 director & 10 percent owner
DM Desktop Metal Inc 2020-12-09 10 percent owner
HOOD Robinhood Markets Inc 2022-05-03 director & 10 percent owner
ACLX Arcellx Inc 2022-12-21 10 percent owner
BGRY Berkshire Grey Inc 2021-07-21 10 percent owner
IONQ IonQ Inc 2021-09-30 10 percent owner
GLUE Monte Rosa Therapeutics Inc 2021-06-23 10 percent owner
SNTI Senti Biosciences Inc 2022-06-08 10 percent owner
GGNNQ Genocea Biosciences Inc 2018-01-19 10 percent owner
RAACU Revolution Acceleration Acquisition Corp 2021-07-21 10 percent owner
KRRO Korro Bio Inc 2024-04-22 10 percent owner

Mohamad Makhzoumi Latest Holdings Summary

Mohamad Makhzoumi currently owns a total of 14 stocks. Among these stocks, Mohamad Makhzoumi owns 23,829,279 shares of Robinhood Markets Inc (HOOD) as of May 3, 2022, with a value of $426 Million and a weighting of 38.14%. Mohamad Makhzoumi owns 4,745,545 shares of Arcellx Inc (ACLX) as of December 21, 2022, with a value of $246 Million and a weighting of 22.05%. Mohamad Makhzoumi also owns 24,471,264 shares of Savara Inc (SVRA) as of July 17, 2023, with a value of $108 Million and a weighting of 9.66%. The other 11 stocks Mirum Pharmaceuticals Inc (MIRM) , Korro Bio Inc (KRRO) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) have a combined weighting of 30.15% among all his current holdings.

Latest Holdings of Mohamad Makhzoumi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOOD Robinhood Markets Inc 2022-05-03 23,829,279 17.88 426,067,509
ACLX Arcellx Inc 2022-12-21 4,745,545 51.92 246,388,696
SVRA Savara Inc 2023-07-17 24,471,264 4.41 107,918,274
MIRM Mirum Pharmaceuticals Inc 2019-07-22 4,186,243 24.46 102,395,504
KRRO Korro Bio Inc 2024-04-22 1,090,793 62.93 68,643,603
AVEO AVEO Pharmaceuticals Inc 2020-06-19 3,952,958 15.00 59,294,370
AKUS Akouos Inc 2020-06-30 4,294,207 13.29 57,070,011
TRVI Trevi Therapeutics Inc 2022-04-11 11,370,376 2.78 31,609,645
INZY Inozyme Pharma Inc 2020-07-28 2,437,689 4.44 10,823,339
MRKR Marker Therapeutics Inc 2021-03-16 1,071,429 4.29 4,596,430
RGLS Regulus Therapeutics Inc 2020-12-04 645,106 2.42 1,561,157
EAR Eargo Inc 2020-10-20 326,001 2.57 837,823
MTCR Metacrine Inc 2021-12-22 2,563,257 0.00 3,589
GNCAQ Genocea Biosciences Inc 2022-05-25 0 0.00 0

Holding Weightings of Mohamad Makhzoumi


Mohamad Makhzoumi Form 4 Trading Tracker

According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 2 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Robinhood Markets Inc is the sale of 1,952 shares on May 3, 2022, which brought Mohamad Makhzoumi around $19,637.

According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 1 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arcellx Inc is the sale of 179 shares on December 21, 2022, which brought Mohamad Makhzoumi around $5,502.

According to the SEC Form 4 filings, Mohamad Makhzoumi has made a total of 1 transactions in Savara Inc (SVRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Savara Inc is the acquisition of 333,333 shares on July 17, 2023, which cost Mohamad Makhzoumi around $999,999.

More details on Mohamad Makhzoumi's insider transactions can be found in the Insider Trading History of Mohamad Makhzoumi table.

Insider Trading History of Mohamad Makhzoumi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mohamad Makhzoumi Trading Performance

GuruFocus tracks the stock performance after each of Mohamad Makhzoumi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mohamad Makhzoumi is -10.7%. GuruFocus also compares Mohamad Makhzoumi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mohamad Makhzoumi within 3 months outperforms 10 times out of 25 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mohamad Makhzoumi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mohamad Makhzoumi

Average Return

-50.09%

Average return per transaction

Outperforming Transactions

8%

2 out of 24 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.04 -10.7 -23.69 -50.09 -42.99 -40.08
Relative Return to S&P 500(%) 3.32 -14.16 -31.97 -67.04 -56.19 -55.01

Mohamad Makhzoumi Ownership Network

Ownership Network List of Mohamad Makhzoumi

No Data

Ownership Network Relation of Mohamad Makhzoumi


Mohamad Makhzoumi Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Mohamad Makhzoumi is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Mohamad Makhzoumi made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Mohamad Makhzoumi Mailing Address

Above is the net worth, insider trading, and ownership report for Mohamad Makhzoumi. You might contact Mohamad Makhzoumi via mailing address: 2855 Sand Hill Road, Menlo Park Ca 94025.

Discussions on Mohamad Makhzoumi

No discussions yet.